Yangyang B. Guo

Ningbo, 315000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications

Machine learning-based identification of basement membrane-related signature to predict recurrence and immunotherapy benefit in bladder cancer.

Machine learning-based identification of basement membrane-related signature to predict recurrence and immunotherapy benefit in bladder cancer.

Journal: Immunologic research
Published: February 11, 2026

Mut-p53 acts as a synthetic lethal partner with E2F3 inhibition in gastric cancer under FGFR1 inhibitor.

Mut-p53 acts as a synthetic lethal partner with E2F3 inhibition in gastric cancer under FGFR1 inhibitor.

Journal: Cellular signalling
Published: February 09, 2026

Copper-EGCG nanoreactor orchestrates dual-metabolic assault and self-amplified cuproptosis for immunogenic prostate cancer therapy.

Copper-EGCG nanoreactor orchestrates dual-metabolic assault and self-amplified cuproptosis for immunogenic prostate cancer therapy.

Journal: Journal of nanobiotechnology
Published: January 23, 2026

Phytic Acid-Based Nanoplatform Mediates Reinforcement of Cuproptosis Induction and Pathway Inhibition.

Phytic Acid-Based Nanoplatform Mediates Reinforcement of Cuproptosis Induction and Pathway Inhibition.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: January 07, 2026

Levistolide A induces endoplasmic reticulum stress-triggered apoptosis via ATF6 in triple-negative breast cancer.

Levistolide A induces endoplasmic reticulum stress-triggered apoptosis via ATF6 in triple-negative breast cancer.

Journal: Toxicology and applied pharmacology
Published: January 06, 2026

Multi-omics analysis reveals the role of the XRCC gene family in diagnosis, prognosis, and immunity in pan-cancer.

Multi-omics analysis reveals the role of the XRCC gene family in diagnosis, prognosis, and immunity in pan-cancer.

Journal: Discover oncology
Published: December 25, 2025

Integration of a glutamine metabolism-based prognostic signature and a synergistic nanotherapeutic strategy targeting metabolic vulnerabilities in prostate cancer.

Integration of a glutamine metabolism-based prognostic signature and a synergistic nanotherapeutic strategy targeting metabolic vulnerabilities in prostate cancer.

Journal: Discover oncology
Published: December 18, 2025

Engineering MnPt Bimetallic Nanozymes for Cascade Enzymatic Therapy and Enhanced Radio-Immunotherapy.

Engineering MnPt Bimetallic Nanozymes for Cascade Enzymatic Therapy and Enhanced Radio-Immunotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 30, 2025

Prostate cancer associated 3 (PCA3) is a potential indicator of the pathological grades of prostate cancer.

Prostate cancer associated 3 (PCA3) is a potential indicator of the pathological grades of prostate cancer.

Journal: Discover oncology
Published: July 14, 2025

Discovery of novel pyrimidine-4,6-diamine-based OLIG2 inhibitors as potent anti-glioblastoma agents.

Discovery of novel pyrimidine-4,6-diamine-based OLIG2 inhibitors as potent anti-glioblastoma agents.

Journal: European journal of medicinal chemistry
Published: May 04, 2025

Correction: Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer.

Correction: Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer.

Journal: Molecular medicine (Cambridge, Mass.)
Published: April 15, 2025

Perioperative administration of CBM588 in colorectal cancer radical surgery: A single-center, randomized controlled trial.

Perioperative administration of CBM588 in colorectal cancer radical surgery: A single-center, randomized controlled trial.

Journal: Cell reports. Medicine
Published: March 17, 2025
Showing 1-12 of 74

Last Updated: 09/26/2026